Stop using nowDrug recall · FDA · Published September 16, 2025
IntegraDose Oxytocin IV Solution Recall: No Oxytocin Present
IntegraDose recalls Oxytocin 30 Units/500 mL IV solution due to testing showing no oxytocin present. This affects patients receiving IV oxytocin for medical use.
“IntegraDose Oxytocin IV Solution Recall: No Oxytocin Present.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31781-integradose-oxytocin-iv-solution-recall-no-oxytocin-present. Based on FDA recall #D-0015-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0015-2026%22&limit=1).
IntegraDose Compounding Services LLC voluntarily recalled Oxytocin 30 Units/500 mL IV bags nationwide on September 16, 2025, after testing revealed the product was subpotent with no oxytocin present, according to the FDA. The recall involves 853 bags distributed across the United States.
How to tell if you have it
Brand: IntegraDose
Product: Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only
NDC: 71139-0012-1
Lot #: 20250620OXY-1
Expiration date: 10/18/2025
Quantity: 853 bags of 500 mL
The hazard
Testing revealed there was no oxytocin in the IV bag, classifying the product as a subpotent drug. The FDA assigned this recall a Class I classification.
Context
GovInfoNow's records show IntegraDose Compounding Services LLC has 6 other recalls on record since September 17, 2021. Other recent recalls of similar products include the IntegraDose Vasopressin 2 Units/2mL Recall (May 18, 2026), the IntegraDose Fentanyl Citrate Recall (May 12, 2026), and the Novadoz Glycopyrrolate Oral Solution Recall (December 15, 2025).
How to tell if you have this one
Check for the product name 'Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride' with NDC 71139-0012-1 and lot number 20250620OXY-1. The expiration date is 10/18/2025.
Brand
IntegraDose
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop Using Now
Discard the product immediately as it contains no oxytocin and may not provide the intended medical treatment.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 36 days after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0015-2026 (September 16, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0015-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.